Uncategorized | Page 3

RevealDx and contextflow team up to improve lung cancer screening in the EU via enhanced nodule characterization

August 3, 2022

RevealDx appoints contextflow as its exclusive distributor in the European Union and selected territories. The companies also announce trial installation discounts for select customers. Seattle, WA – August 3, 2022 – Chest specialists RevealDx and contextflow announced today an agreement for exclusive distribution of RevealDx’ products in the EU and other selected territories. The companies … RevealDx and contextflow team up to improve lung cancer screening in the EU via enhanced nodule characterization

Volpara Health cements lung screening expansion via strategic relationship with Seattle-based lung AI company RevealDx

September 20, 2021

Volpara further expands its footprint in the lung cancer screening market with a strategic partnership with Seattle-based lung AI company Precision Medical Ventures (PMV), trading as RevealDx

Rebranding of Mindshare Medical to RevealDx

September 9, 2021

Precision Medical Ventures announces the rebranding of Mindshare Medical to RevealDx and the appointment of Chris Wood as CEO.

Acquisition

March 23, 2021

Precision Medical Ventures announces the acquisition of Mindshare Medical to accelerate commercialization of RevealAI-Lung, a CADx software application with EU and Canadian regulatory approval.